For all the misery that the pandemic has wrought, it has also opened up a vast storehouse of knowledge about medical issues beyond COVID-19. While it's still too early to draw conclusions, evidence is emerging of links between ...
Feb 16, 2022
0
5
As messenger substances, interferons stimulate various responses of immune cells and play a key role in activating the immune system. They are proven active agents against various diseases, especially type I interferon alpha ...
Feb 14, 2022
0
36
What is going on at the single-cell level in the first days of SARS-CoV-2 infection in the lungs?
Feb 8, 2022
0
67
The world knows SARS-CoV-2 intimately now, but there are more than 200 virus species capable of infecting humans and causing disease. And they all want to do the same thing: Invade the host cells, hijack each cell's machinery ...
Jan 18, 2022
0
184
Research led by scientists at the Jonsson Comprehensive Cancer Center (JCCC) at UCLA provides new insights into molecular "crosstalk" in pancreas cancer cells, identifying vulnerabilities that could provide a target for therapeutic ...
Jan 11, 2022
0
47
Scientists have just slotted into place a big piece of the puzzle that explains how our blood cells mount their first line of defense against viruses. They hope this discovery will help them one day better control the response ...
Jan 10, 2022
0
110
Fundamental differences in the immune response of adults and children can help to explain why children are much less likely to become seriously ill from SARS-CoV-2, according to new research from the Wellcome Sanger Institute, ...
Dec 22, 2021
0
509
Scientists have shed new light on early events in the battle between COVID-19 and the immune system in the nose, a key entry point for the virus.
Dec 7, 2021
0
267
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
Oct 20, 2021
0
6
A clinical trial has found that treatment with the immunomodulator interferon beta-1a plus the antiviral remdesivir was not superior to treatment with remdesivir alone in hospitalized adults with COVID-19 pneumonia. In addition, ...
Oct 18, 2021
0
54
